Skip to content

Study · Case report or series · 1996

1 result

Continuous infusion of methylene blue for septic shock.

Brown G, Frankl D, Phang T

Postgraduate medical journal1 Oct 1996Cited by 39 (Europe PMC)

PMID8977944 (opens in a new tab)PMCIDPMC2398584 (opens in a new tab)DOI10.1136/pgmj.72.852.612 (opens in a new tab)PepBankPUB-08977944
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a sepsis case report, continuous methylene blue infusion produced a beneficial hemodynamic effect.

    In plain wordsContinuous methylene blue infusion improved circulation in a sepsis case report.

    Peptide
    Methylene blue
    Outcome
    Not applicableHemodynamic effect
    Study

    n: not reported in source

    Outcome group
    Heart function · Cardiovascular
    Studied dose
    Dose not stated · continuous infusionAs given in this study (human).

    Source sentences

    Summary
    The case report presented here demonstrates a beneficial haemodynamic eect of continuous infusion of methylene blue during sepsis.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.